Sera Prognostics (SERA) Amortization of Deferred Charges (2022 - 2026)
Sera Prognostics (SERA) posted Amortization of Deferred Charges of $67000.0 for Q1 2026, up 1.52% on a QoQ basis from $66000.0 in Q4 2025, and down 55.03% year-over-year from $149000.0 in Q1 2025.
Sera Prognostics (SERA) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Sera Prognostics' Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $67000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges fell 55.03% year-over-year to $67000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $410000.0 (down 29.07% YoY) and the FY2025 annual result came in at $492000.0, down 13.23% from the prior year.
- Amortization of Deferred Charges was $67000.0 for Q1 2026 at Sera Prognostics, up from $66000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $152000.0 in Q2 2025 and bottomed at $66000.0 in Q4 2025.
- A 5-year average of $124352.9 and a median of $131000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges climbed 16.96% — and 2026, when it slumped 55.03%.
- Sera Prognostics' Amortization of Deferred Charges stood at $125000.0 in 2022, then grew by 8.0% to $135000.0 in 2023, then rose by 8.15% to $146000.0 in 2024, then slumped by 54.79% to $66000.0 in 2025, then climbed by 1.52% to $67000.0 in 2026.
- Business Quant data shows SERA's Amortization of Deferred Charges at $67000.0 in Q1 2026, $66000.0 in Q4 2025, and $125000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Sera Prognostics | 102.28 Mn | 102.28 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67,000.00 |
| Mar 31, 2026 | 67,000.00 |
| Dec 31, 2025 | 66,000.00 |
| Dec 31, 2025 | 66,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 152,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 146,000.00 |
| Dec 31, 2024 | 146,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 140,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Dec 31, 2023 | 135,000.00 |
| Dec 31, 2023 | 135,000.00 |